Gastrointestinal Stromal Tumor Market Report 2026
Download Free Sample Buy Now
Gastrointestinal Stromal Tumor Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Gastrointestinal Stromal Tumor Market Report 2026

Global Outlook – By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Indication (Stomach, Small Intestine, Others Indications), By End-User (Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gastrointestinal Stromal Tumor Market Overview

• Gastrointestinal Stromal Tumor market size has reached to $1.36 billion in 2025

• Expected to grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 8%

• Growth Driver: Growing Incidence Of Stomach Cancer To Boost The Market

• Market Trend: Clinical Advancements Reinforce The Expansion Of Targeted Therapies For GIST Patients

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastrointestinal Stromal Tumor Market?

A gastrointestinal stromal tumor (GIST) is a type of rare, non-epithelial tumor that originates in the gastrointestinal (GI) tract. These are most commonly developed in the stomach or the small intestine, but they can occur anywhere along the GI tract, from the esophagus to the rectum.

The main treatment types of gastrointestinal stromal tumors are chemotherapy, targeted therapy, and others. Chemotherapy is a medical treatment that uses powerful drugs to target and kill rapidly dividing cells in the body, including cancer cells. It is indicated for various indications such as stomach, small intestine, and others, by different end-users including hospitals, clinics, specialized cancer treatment centers, and others.

Gastrointestinal Stromal Tumor Market Global Report 2026 Market Report bar graph

What Is The Gastrointestinal Stromal Tumor Market Size and Share 2026?

The gastrointestinal stromal tumor market size has grown strongly in recent years. It will grow from $1.36 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to approval of imatinib therapy, improved tumor classification, expansion of oncology care centers, increased awareness of rare gi tumors, availability of surgical interventions.

What Is The Gastrointestinal Stromal Tumor Market Growth Forecast?

The gastrointestinal stromal tumor market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to development of next-generation targeted therapies, growth in precision diagnostics, increased clinical trials, expansion of personalized cancer treatment, improved survival outcomes. Major trends in the forecast period include rising use of targeted tyrosine kinase inhibitors, increased focus on molecular tumor profiling, expansion of precision oncology approaches, growth in surgical and drug combination therapy, improved long-term disease management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gastrointestinal Stromal Tumor Market Segmentation

1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types

2) By Indication: Stomach, Small Intestine, Others Indications

3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users

Subsegments:

1) By Chemotherapy: Traditional Chemotherapy Agents, Combination Chemotherapy Regimens

2) By Targeted Therapy: Tyrosine Kinase Inhibitors, Other Targeted Agents

3) By Other Treatment Types: Surgery, Radiation Therapy, Clinical Trials For Novel Therapies

What Is The Driver Of The Gastrointestinal Stromal Tumor Market?

The growing incidence of stomach cancer is expected to propel the growth of the gastrointestinal stromal tumor market going forward. Stomach cancer refers to the uncontrolled growth and multiplication of malignant cells in the lining of the stomach. while gastrointestinal stromal tumors (GISTs) can occur in the stomach, they are distinct from stomach cancer. When two separate tumors collide and merge into one, patients with GISTs have been found to have an increased risk of developing additional cancers, including small bowel adenocarcinoma. For instance, in January 2024, according to the American Cancer Society, a US-based professional organization, around 26,890 new cases of stomach cancer and 10,880 deaths are anticipated in the U.S. for 2024, accounting for 1.5% of all new cancer diagnoses. Therefore, the growing incidence of stomach cancer is driving the growth of the gastrointestinal stromal tumor industry.

Key Players In The Global Gastrointestinal Stromal Tumor Market

Major companies operating in the gastrointestinal stromal tumor market are Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd.

Global Gastrointestinal Stromal Tumor Market Trends and Insights

Major companies operating in the gastrointestinal stromal tumor market are innovating new drugs such as signal transduction and targeted therapy to improve treatment efficacy, address resistance to existing therapies, and meet unmet clinical needs. Signal transduction and targeted therapy refer to treatments designed to block or modify specific cellular signaling pathways that drive tumor growth and survival. For instance, in November 2025, Ascentage Pharma Group International Inc., a China-based commercial-stage biopharmaceutical company, announced the publication of Phase Ib clinical data for olverembatinib (HQP1351) in Signal Transduction and Targeted Therapy, highlighting promising efficacy and safety in SDH-deficient gastrointestinal stromal tumors (GIST) and identifying a new antitumor mechanism involving lipid metabolism modulation.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastrointestinal Stromal Tumor Market?

In February 2025, GSK plc, a U.K.-based global biopharmaceutical company providing prescription medicines, vaccines, and specialty treatments, acquired IDRx, Inc. for an undisclosed amount. With this acquisition, GSK aims to strengthen its precision oncology portfolio and expand its pipeline of targeted therapies for gastrointestinal stromal tumors. IDRx, Inc. is a U.S.-based clinical-stage biotechnology company developing precision therapies for rare cancers, with a focus on molecularly driven GIST treatments, including its lead KIT tyrosine kinase inhibitor, IDRX 42.

Regional Outlook

North America was the largest region in the gastrointestinal stromal tumor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastrointestinal Stromal Tumor Market?

The gastrointestinal stromal tumor market includes revenues earned by entities by providing services such as diagnostic services, pathology services, pathology services, and pathology services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal stromal tumor market also includes sales of targeted therapy, chemotherapy, radiation therapy. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastrointestinal Stromal Tumor Market Report 2026?

The gastrointestinal stromal tumor market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal stromal tumor industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gastrointestinal Stromal Tumor Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.46 billion
Revenue Forecast In 2035 $1.98 billion
Growth Rate CAGR of 6.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Indication, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastrointestinal Stromal Tumor Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastrointestinal Stromal Tumor Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastrointestinal Stromal Tumor Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastrointestinal Stromal Tumor Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Use Of Targeted Tyrosine Kinase Inhibitors

4.2.2 Increased Focus On Molecular Tumor Profiling

4.2.3 Expansion Of Precision Oncology Approaches

4.2.4 Growth In Surgical And Drug Combination Therapy

4.2.5 Improved Long-Term Disease Management

5. Gastrointestinal Stromal Tumor Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialized Cancer Treatment Centers

5.3 Specialty Oncology Clinics

5.4 Research Institutes

5.5 Diagnostic Centers

6. Gastrointestinal Stromal Tumor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastrointestinal Stromal Tumor Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastrointestinal Stromal Tumor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastrointestinal Stromal Tumor Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastrointestinal Stromal Tumor Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastrointestinal Stromal Tumor Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastrointestinal Stromal Tumor Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastrointestinal Stromal Tumor Market Segmentation

9.1. Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy, Targeted Therapy, Other Treatment Types

9.2. Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stomach, Small Intestine, Others Indications

9.3. Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users

9.4. Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Traditional Chemotherapy Agents, Combination Chemotherapy Regimens

9.5. Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tyrosine Kinase Inhibitors, Other Targeted Agents

9.6. Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Surgery, Radiation Therapy, Clinical Trials For Novel Therapies

10. Gastrointestinal Stromal Tumor Market Regional And Country Analysis

10.1. Global Gastrointestinal Stromal Tumor Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastrointestinal Stromal Tumor Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastrointestinal Stromal Tumor Market

11.1. Asia-Pacific Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastrointestinal Stromal Tumor Market

12.1. China Gastrointestinal Stromal Tumor Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastrointestinal Stromal Tumor Market

13.1. India Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastrointestinal Stromal Tumor Market

14.1. Japan Gastrointestinal Stromal Tumor Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastrointestinal Stromal Tumor Market

15.1. Australia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastrointestinal Stromal Tumor Market

16.1. Indonesia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastrointestinal Stromal Tumor Market

17.1. South Korea Gastrointestinal Stromal Tumor Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastrointestinal Stromal Tumor Market

18.1. Taiwan Gastrointestinal Stromal Tumor Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastrointestinal Stromal Tumor Market

19.1. South East Asia Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastrointestinal Stromal Tumor Market

20.1. Western Europe Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastrointestinal Stromal Tumor Market

21.1. UK Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastrointestinal Stromal Tumor Market

22.1. Germany Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastrointestinal Stromal Tumor Market

23.1. France Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastrointestinal Stromal Tumor Market

24.1. Italy Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastrointestinal Stromal Tumor Market

25.1. Spain Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastrointestinal Stromal Tumor Market

26.1. Eastern Europe Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastrointestinal Stromal Tumor Market

27.1. Russia Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastrointestinal Stromal Tumor Market

28.1. North America Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastrointestinal Stromal Tumor Market

29.1. USA Gastrointestinal Stromal Tumor Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastrointestinal Stromal Tumor Market

30.1. Canada Gastrointestinal Stromal Tumor Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastrointestinal Stromal Tumor Market

31.1. South America Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastrointestinal Stromal Tumor Market

32.1. Brazil Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastrointestinal Stromal Tumor Market

33.1. Middle East Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastrointestinal Stromal Tumor Market

34.1. Africa Gastrointestinal Stromal Tumor Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Segmentation By Indication, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastrointestinal Stromal Tumor Market Regulatory and Investment Landscape

36. Gastrointestinal Stromal Tumor Market Competitive Landscape And Company Profiles

36.1. Gastrointestinal Stromal Tumor Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastrointestinal Stromal Tumor Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastrointestinal Stromal Tumor Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Gastrointestinal Stromal Tumor Market Other Major And Innovative Companies

GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd.

38. Global Gastrointestinal Stromal Tumor Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastrointestinal Stromal Tumor Market

40. Gastrointestinal Stromal Tumor Market High Potential Countries, Segments and Strategies

40.1 Gastrointestinal Stromal Tumor Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastrointestinal Stromal Tumor Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastrointestinal Stromal Tumor Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gastrointestinal Stromal Tumor Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gastrointestinal Stromal Tumor Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gastrointestinal Stromal Tumor Market, Supply Chain Analysis
  • Table 4: Global Gastrointestinal Stromal Tumor Market, Major Raw Material Providers
  • Table 5: Global Gastrointestinal Stromal Tumor Market, Major Resource Providers
  • Table 6: Global Gastrointestinal Stromal Tumor Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gastrointestinal Stromal Tumor Market, Major Distributors And Channel Partners
  • Table 8: Global Gastrointestinal Stromal Tumor Market, Key Technologies & Future Trends
  • Table 9: Global Gastrointestinal Stromal Tumor Market, Major Trends
  • Table 10: Global Gastrointestinal Stromal Tumor Market, Major End Users
  • Table 11: Global Gastrointestinal Stromal Tumor Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gastrointestinal Stromal Tumor Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gastrointestinal Stromal Tumor Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gastrointestinal Stromal Tumor Market - TAM, US$ Billion, 2025
  • Table 15: Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gastrointestinal Stromal Tumor Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gastrointestinal Stromal Tumor Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Gastrointestinal Stromal Tumor Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Gastrointestinal Stromal Tumor Market - Company Scoring Matrix
  • Table 97: Pfizer Inc. Financial Performance
  • Table 98: F. Hoffmann-La Roche AG Financial Performance
  • Table 99: Bayer AG Financial Performance
  • Table 100: Novartis AG Financial Performance
  • Table 101: Merck & Co. Inc. Financial Performance
  • Table 102: Global Gastrointestinal Stromal Tumor Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Gastrointestinal Stromal Tumor Market, Competitive Dashboard
  • Table 104: Global Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 106: Global, Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 107: Global, Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Gastrointestinal Stromal Tumor Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gastrointestinal Stromal Tumor Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gastrointestinal Stromal Tumor Market, Supply Chain Analysis
  • Figure 4: Global Gastrointestinal Stromal Tumor Market, Major Raw Material Providers
  • Figure 5: Global Gastrointestinal Stromal Tumor Market, Major Resource Providers
  • Figure 6: Global Gastrointestinal Stromal Tumor Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gastrointestinal Stromal Tumor Market, Major Distributors And Channel Partners
  • Figure 8: Global Gastrointestinal Stromal Tumor Market, Key Technologies & Future Trends
  • Figure 9: Global Gastrointestinal Stromal Tumor Market, Major Trends
  • Figure 10: Global Gastrointestinal Stromal Tumor Market, Major End Users
  • Figure 11: Global Gastrointestinal Stromal Tumor Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gastrointestinal Stromal Tumor Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gastrointestinal Stromal Tumor Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gastrointestinal Stromal Tumor Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gastrointestinal Stromal Tumor Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gastrointestinal Stromal Tumor Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gastrointestinal Stromal Tumor Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Gastrointestinal Stromal Tumor Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Gastrointestinal Stromal Tumor Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Gastrointestinal Stromal Tumor Market - Company Scoring Matrix
  • Figure 97: Pfizer Inc. Financial Performance
  • Figure 98: F. Hoffmann-La Roche AG Financial Performance
  • Figure 99: Bayer AG Financial Performance
  • Figure 100: Novartis AG Financial Performance
  • Figure 101: Merck & Co. Inc. Financial Performance
  • Figure 102: Global Gastrointestinal Stromal Tumor Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Gastrointestinal Stromal Tumor Market, Competitive Dashboard
  • Figure 104: Global Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 106: Global, Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 107: Global, Gastrointestinal Stromal Tumor Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Gastrointestinal Stromal Tumor Market Report 2026 - Global Outlook – By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By Indication (Stomach, Small Intestine, Others Indications), By End-User (H...

Gastric Cancer Diagnostic Procedure Market Report 2026 - Global Outlook – By Procedure Type (Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multipl...

Germ Cell Tumor Market Report 2026 - Global Outlook – By Disease (Testicular, Ovarian, Other Diseases), By Treatment Type (Chemotherapy, Immunotherapy), By Route Of Administration (Oral, Intravenous, Intraperitoneal), By...

Gastrointestinal Endoscopy Market Report 2026 - Global Outlook – By Product (Endoscopes, Camera Heads, Visualization Systems, Biopsy Devices, Capsule Endoscopes, Transmitters And Receivers, Robot-Assisted Endoscopes), By...

Pheochromocytoma Market Report 2026 - Global Outlook – By Type (Adrenal Pheochromocytoma, Extra-Adrenal Pheochromocytoma), By Treatment (Medication, Surgery, Radionuclide Treatment, Other Treatments), By Diagnosis (Labor...

Desmoid Tumors Market Report 2026 - Global Outlook – By Treatment (Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments), By Diagnosi...

Esophageal Cancer Market Report 2026 - Global Outlook – By Type (Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types), By Treatment Type (Chemotherapy, Targeted Therapy, Other Treatment Types), By ...

Gastroesophageal Junction Adenocarcinoma Therapeutics Market Report 2026 - Global Outlook – By Drug (Trastuzumab, Ramucirumab), By Diagnosis (Endoscopy, X-ray, Computed Tomography (CT) Scan, Positron Emission Tomography ...

Frequently Asked Questions

The Gastrointestinal Stromal Tumor market was valued at $1.36 billion in 2025, increased to $1.46 billion in 2026, and is projected to reach $1.98 billion by 2030.

The global Gastrointestinal Stromal Tumor market is expected to grow at a CAGR of 8.0% from 2026 to 2035 to reach $1.98 billion by 2035.

Some Key Players in the Gastrointestinal Stromal Tumor market Include, Pfizer Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck & Co. Inc., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., NATCO Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd. .

Major trend in this market includes: Clinical Advancements Reinforce The Expansion Of Targeted Therapies For GIST Patients. For further insights on this market. request a sample here

North America was the largest region in the gastrointestinal stromal tumor market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us